Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy
- 1 October 1996
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 254 (2) , 113-129
- https://doi.org/10.1016/0009-8981(96)06378-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Serum PAPP‐A and free β‐hCG are first‐trimester screening markers for down syndromePrenatal Diagnosis, 1994
- Maternal serum human chorionic gonadotrophin and pregnancy‐associated plasma protein a, markers for fetal down syndrome at 8–14 weeksPrenatal Diagnosis, 1994
- Serum PAPP‐A measurements in first‐trimester screening for Down syndromePrenatal Diagnosis, 1993
- Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancyPrenatal Diagnosis, 1993
- First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.BMJ, 1992
- A two-site immunoradiometric assay for human pregnancy-associated plasma protein A (PAPP-A) using monoclonal antibodiesJournal of Immunological Methods, 1986
- The development and validation of a radioimmunoassay for human Pregnancy-Associated Plasma Protein A (PAPP-A)Archiv für Gynäkologie, 1984
- Development of a Radioimmunoassay for Pregnancy-Associated Plasma Protein A and Establishment of Normal Levels in the First Trimester of PregnancyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1983
- Radioimmunoassay for the Measurement of Pregnancy-Associated Plasma Protein-A (PAPP-A) in HumansBiology of Reproduction, 1981
- Characterization of four human pregnancy-associated plasma proteinsAmerican Journal of Obstetrics and Gynecology, 1974